Pixium Vision - Pixium appoints new CEO
Pixium Vision announced that Lloyd Diamond will serve as the chief executive officer (CEO) of Pixium Vision, effective 13 May 2019. Mr Diamond, a US citizen, is an experienced executive and CEO in the MedTech sector, with 25 years of disruptive technology commercialization experience in the life sciences sector. He most recently served as the CEO of Precise Light Surgical, a medical device company based in Silicon Valley. Previously, he was the CEO of Bonesupport, a European orthobiologic company, where he oversaw rapid market penetration in Europe and the US, leading to a successful IPO on the Nasdaq OMX. He also has relevant experience in the ophthalmology segment as he was responsible for managing Lumenis’s global surgical and vision franchises.Pixium Vision SA is a company that specializes in sensorial neuromodulation. Co. is also collaborating with scientific groups and clinicians at research institutes and clinical centers around the world, including Stanford University (USA). Co. is developing and aims to commercialize Bionic Vision Systems (BVS) – namely active implantable medical devices to treat blindness caused by degeneration of photoreceptor cells in the retina.
Edison is an investment research and advisory company, with offices in North America, Europe, the Middle East and AsiaPac. The heart of Edison is our world renowned equity research platform and deep multi-sector expertise. At Edison Investment Research, our research is widely read by international investors, advisors and stakeholders. Edison Advisors leverages our core research platform to provide differentiated services including investor relations and strategic consulting.
.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.